British Journal of Haematology

Recurrent episodes of fever and pancytopenia due to haemophagocytosis during maintenance therapy for acute myeloid leukaemia
pp. 605-605(1)
Authors: Sovinz, P.; Lackner, H.; Urban, C.

Isolated tongue amyloid in a patient with multiple myeloma
pp. 606-606(1)
Authors: Went, Richard; Chan-Lam, Dominic; Thornhill, Martin

Use of rituximab in diffuse large B-cell lymphoma in the salvage setting
pp. 607-621(15)
Author: Gisselbrecht, Christian

Antiangiogenesis in haematological malignancies
pp. 622-631(10)
Authors: Li, William W.; Hutnik, Michelle; Gehr, Gerald

Understanding haemophilic arthropathy: an exploration of current open issues
pp. 632-640(9)
Authors: Jansen, Nathalie W. D.; Roosendaal, Goris; Lafeber, Floris P. J. G.

Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation
pp. 641-653(13)
Authors: Shi, Jumei; Tricot, Guido; Szmania, Susann; Rosen, Nancy; Garg, Tarun K.; Malaviarachchi, Priyangi A.; Moreno, Amberly; DuPont, Bo; Hsu, Katharine C.; Baxter-Lowe, Lee Ann; Cottler-Fox, Michele; Shaughnessy Jr, John D.; Barlogie, Bart; van Rhee, Frits

Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma
pp. 654-660(7)
Authors: Mark, Tomer; Jayabalan, David; Coleman, Morton; Pearse, Roger N.; Wang, Y. Lynn; Lent, Richard; Christos, Paul J.; Lee, Joong W.; Agrawal, Yash P.; Matthew, Susan; Ely, Scott; Mazumdar, Madhu; Cesarman, Ethel; Leonard, John P.; Furman, Richard R.; Chen-Kiang, Selina; Niesvizky, Ruben

Nuclear factor-κB as a potential therapeutic target for the novel cytotoxic agent LC-1 in acute myeloid leukaemia
pp. 661-671(11)
Authors: Jenkins, Christopher; Hewamana, Saman; Gilkes, Amanda; Neelakantan, Sundar; Crooks, Peter; Mills, Ken; Pepper, Chris; Burnett, Alan

Remission induction therapy containing rituximab markedly improved the outcome of untreated mature B cell lymphoma
pp. 672-680(9)
Authors: Nagai, Hirokazu; Yano, Takahiro; Watanabe, Tomoyuki; Uike, Naokuni; Okamura, Seiichi; Hanada, Shuichi; Kawano, Fumio; Sunami, Kazutaka; Inoue, Nobumasa; Sawamura, Morio; Nishiura, Tetsuo; Hotta, Tomomitsu; Horibe, Keizo

Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia
pp. 681-689(9)
Authors: Latagliata, Roberto; Breccia, Massimo; Fazi, Paola; Iacobelli, Simona; Martinelli, Giovanni; Di Raimondo, Francesco; Sborgia, Marco; Fabbiano, Francesco; Pirrotta, Maria Teresa; Zaccaria, Alfonso; Amadori, Sergio; Caramatti, Cecilia; Falzetti, Franca; Candoni, Anna; Mattei, Daniele; Morselli, Monica; Alimena, Giuliana; Vignetti, Marco; Baccarani, Michele; Mandelli, Franco

Patients' experience of chronic lymphocytic leukaemia: baseline health-related quality of life results from the LRF CLL4 trial
pp. 690-697(8)
Authors: Else, Monica; Smith, Alastair G.; Cocks, Kim; Richards, Sue M.; Crofts, Shirley; Wade, Rachel; Catovsky, Daniel

Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro
pp. 698-706(9)
Authors: Amrein, Lilian; Hernandez, Tiffany A.; Ferrario, Cristiano; Johnston, James; Gibson, Spencer B.; Panasci, Lawrence; Aloyz, Raquel

Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome - a phase-II study
pp. 707-715(9)
Authors: Metzgeroth, Georgia; Walz, Christoph; Erben, Philipp; Popp, Helena; Schmitt-Graeff, Annette; Haferlach, Claudia; Fabarius, Alice; Schnittger, Susanne; Grimwade, David; Cross, Nicholas C. P.; Hehlmann, Rüdiger; Hochhaus, Andreas; Reiter, Andreas

Fluorescence in situ hybridization characterization of ider(20q) in myelodysplastic syndrome
pp. 716-720(5)
Authors: Douet-Guilbert, N.; Laï, J. L.; Basinko, A.; Gueganic, N.; Andrieux, J.; Pollet, B.; Plantier, I.; Delattre, C.; Crépin, O.; Corm, S.; Le Bris, M. J.; Morel, F.; De Braekeleer, M.

Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay
pp. 721-726(6)
Authors: Bryant, Adam; Low, Joyce; Austin, Steven; Joseph, Joanne E.

The influence of polymorphisms of VKORC1 and CYP2C9 on major gastrointestinal bleeding risk in anticoagulated patients
pp. 727-733(7)
Authors: Montes, Ramón; Nantes, Óscar; Alonso, Álvaro; Zozaya, José M.; Hermida, José

Strongly increased levels of fibrinogen elastase degradation products in patients with ischemic stroke
pp. 734-737(4)
Authors: de Lau, Lonneke M. L.; Cheung, Elim Y. L.; Kluft, Cornelis; Leebeek, Frank W. G.; Meijer, Piet; Laterveer, Ria; Dippel, Diederik W. J.; de Maat, Moniek P. M.

Outcomes of older patients (≥60 years) with acquired aplastic anaemia treated with immunosuppressive therapy
pp. 738-743(6)
Authors: Kao, Susan Y.; Xu, Wei; Brandwein, Joseph M.; Lipton, Jeffrey H.; Messner, Hans A.; Minden, Mark D.; Schimmer, Aaron D.; Schuh, Andre C.; Yee, Karen; Gupta, Vikas

Persistence of CD33 expression at relapse in CD33⁺ acute myeloid leukaemia patients after receiving Gemtuzumab in the course of the disease
pp. 744-746(3)
Authors: Chevallier, Patrice; Robillard, Nelly; Ayari, Sameh; Guillaume, Thierry; Delaunay, Jacques; Mechinaud, Francoise; Avet-Loiseau, Herve; Mohty, Mohamad; Harousseau, Jean-Luc; Garand, Richard

Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: the causes might be more heterogeneous than in thalassaemia
pp. 746-747(2)
Authors: Mariani, Raffaella; Pelucchi, Sara; Pozzi, Matteo; Paolini, Valentina; Piperno, Alberto

Treosulphan as an alternative to busulphan for myeloablative conditioning in paediatric allogeneic transplantation
pp. 748-751(4)
Authors: Cutting, Rob; Mirelman, Anna; Vora, Ajay

Transmission of chronic lymphocytic leukaemia from a blood stem cell sibling donor to the recipient
pp. 751-753(3)
Authors: Nahi, H.; Jansson, M.; Sander, B.; Ljungman, P.; Hägglund, H.

The use of intravenous iron in patients with cancer related anaemia: don't overlook iron deficiency anaemia in colorectal cancer
pp. 754-754(1)
Authors: Fitzgerald, J. E. F.; Simpson, J. A. D.; Acheson, A. G.

The use of intravenous iron in patients with cancer related anaemia: don't overlook iron deficiency anaemia in colorectal cancer - response to Fitzgerald et al
pp. 755-755(1)
Authors: Littlewood, T. J.; Alikhan, R.

Corrigendum
pp. 756-756(1)

Corrigendum
pp. 757-757(1)

Book Review
pp. 758-758(1)
Author: Bain, Barbara